Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells

Citation
D. Mcdonald et al., Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells, GENE THER, 6(9), 1999, pp. 1512-1519
Citations number
20
Categorie Soggetti
Molecular Biology & Genetics
Journal title
GENE THERAPY
ISSN journal
09697128 → ACNP
Volume
6
Issue
9
Year of publication
1999
Pages
1512 - 1519
Database
ISI
SICI code
0969-7128(199909)6:9<1512:CAAR(A>2.0.ZU;2-O
Abstract
The role of two receptors, previously proposed to mediate the entry of aden oviruses into human cells, the coxsackie and adenovirus receptor (CAR) and the major histocompatibility complex (MHC) class I heavy chain has been inv estigated. The expression of MHC class I in many tumours is reduced or abse nt, therefore if this were a means by which adenoviruses gained entry into cells, it would have important implications for their application in cancer treatment. In order to determine if MHC class I heavy chain is involved in adenovirus type 5 (Ad5) uptake, the binding of recombinant Ad5 fibre knob domain (which mediates viral attachment) to human cell lines that had great ly different levels of surface MHC class I was studied. We also created der ivatives of a non-permissive Chinese hamster ovary (CHO) cell line that exp ressed human class I (HLA-A2) and found that these cells did not bind fibre or take up virus. In addition, the extracellular domain of CAR was express ed in E. coli and used to generate a polyclonal anti-CAR antibody. This ant ibody blocked both I-125 labelled fibre knob binding and virus uptake. Thus CAR, and not MHC class I, is a receptor for human adenoviruses in cultured tumour cells. Tissue CAR levels may therefore be an important factor in th e efficiency of adenovirus-mediated gene therapy.